Literature DB >> 16583298

A method for analyzing disease-specific mortality with missing cause of death information.

Ping K Ruan1, Robert J Gray.   

Abstract

In this paper, we examine a method for analyzing competing risks data where the failure type of interest is missing or incomplete, but where there is an intermediate event, and only patients who experience the intermediate event can die of the cause of interest. In some applications, a method called "log-rank subtraction" has been applied to these problems. There has been no systematic study of this methodology, though. We investigate the statistical properties of the method and further propose a modified method by including a weight function in the construction of the test statistic to correct for potential biases. A class of tests is then proposed for comparing the disease-specific mortality in the two groups. The tests are based on comparing the difference of weighted log-rank scores for the failure type of interest. We derive the asymptotic properties for the modified test procedure. Simulation studies indicate that the tests are unbiased and have reasonable power. The results are also illustrated with data from a breast cancer study.

Entities:  

Mesh:

Year:  2006        PMID: 16583298     DOI: 10.1007/s10985-005-7219-2

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  5 in total

1.  Multiple imputation methods for estimating regression coefficients in the competing risks model with missing cause of failure.

Authors:  K Lu; A A Tsiatis
Journal:  Biometrics       Date:  2001-12       Impact factor: 2.571

2.  Missing cause of death information in the analysis of survival data.

Authors:  J Andersen; E Goetghebeur; L Ryan
Journal:  Stat Med       Date:  1996-10-30       Impact factor: 2.373

3.  Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1998-05-16       Impact factor: 79.321

4.  Nonparametric estimation for partially-complete time and type of failure data.

Authors:  G E Dinse
Journal:  Biometrics       Date:  1982-06       Impact factor: 2.571

5.  Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials.

Authors: 
Journal:  N Engl J Med       Date:  1995-11-30       Impact factor: 91.245

  5 in total
  3 in total

1.  Extended CCR5 Blockade for Graft-versus-Host Disease Prophylaxis Improves Outcomes of Reduced-Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial.

Authors:  Ran Reshef; Alex Ganetsky; Edward P Acosta; Robin Blauser; Lisa Crisalli; Jessica McGraw; Noelle V Frey; Elizabeth O Hexner; James A Hoxie; Alison W Loren; Selina M Luger; James Mangan; Edward A Stadtmauer; Rosemarie Mick; Robert H Vonderheide; David L Porter
Journal:  Biol Blood Marrow Transplant       Date:  2018-10-10       Impact factor: 5.742

2.  Testing the treatment effect on competing causes of death in oncology clinical trials.

Authors:  Federico Rotolo; Stefan Michiels
Journal:  BMC Med Res Methodol       Date:  2014-05-29       Impact factor: 4.615

3.  A Multi-Center Competing Risks Model and Its Absolute Risk Calculation Approach.

Authors:  Jintao Wang; Zhongshang Yuan; Yi Liu; Fuzhong Xue
Journal:  Int J Environ Res Public Health       Date:  2019-09-16       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.